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Abstract
Background: While several cell types are known to contribute to bone formation, the major
player is a common bone matrix-secreting cell type, the osteoblast. Chondrocytes, which plays
critical roles at several stages of endochondral ossification, and osteoblasts are derived from
common precursors, and both intrinsic cues and signals from extrinsic cues play critical roles in the
lineage decision of these cell types. Several studies have shown that cell fate commitment within
the osteoblast lineage requires sequential, stage-specific signaling to promote osteoblastic
differentiation programs. In osteoblastic differentiation, the functional mechanisms of
transcriptional regulators have been well elucidated, however the exact roles of extrinsic
molecules in osteoblastic differentiation are less clear.
Results: We identify a novel gene, obif (osteoblast induction factor), encoding a transmembrane
protein that is predominantly expressed in osteoblasts. During mouse development, obif is initially
observed in the limb bud in a complementary pattern to Sox9 expression. Later in development,
obif is highly expressed in osteoblasts at the stage of endochondral ossification. In cell line models,
obif  is up-regulated during osteoblastic differentiation. Exogenous obif  expression stimulates
osteoblastic differentiation and obif  knockdown inhibits osteoblastic differentiation in
preosteblastic MC3T3-E1 cells. In addition, the extracellular domain of obif protein exhibits
functions similar to the full-length obif protein in induction of MC3T3-E1 differentiation.
Conclusions: Our results suggest that obif plays a role in osteoblastic differentiation by acting as
a ligand.
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Background
The skeleton is a multifunctional system with physiologi-
cal roles in providing a rigid framework and support, act-
ing as the primary storage site for mineral salts, and
functioning in hematopoiesis. While several cell types are
known to contribute to bone formation, the major player
is a common bone matrix-secreting cell type, the osteob-
last.
Chondrocytes, which play critical roles at several stages of
endochondral ossification, and osteoblasts are derived
from common precursors, and both intrinsic cues and sig-
nals from extrinsic cues play critical roles in the lineage
decision of these cell types [1-3]. The targeted mutation of
Runx2 or Osterix, transcription regulators highly expressed
in osteoblast progenitors, result in the lack of mature oste-
oblasts, demonstrating that these factors are essential for
osteoblastogenesis [4-7]. Several studies have shown that
cell fate commitment within the osteoblast lineage
requires sequential, stage-specific, Ihh and canonical Wnt/
β-catenin signaling to promote osteoblastic, and also to
block chondrogenic, differentiation programs [8-11].
Another recent report shows that the inhibitory effect of
Sox9  on osteoblastic and chondrocyte maturation via
repression of Runx2 function is an essential mechanism
for osteochondroprogenitor cell fate determination [12].
Most bones are formed by endochondral ossification in
which mesenchymal condensations differentiate into
chondrocytes, forming a cartilaginous template prefigur-
ing the future skeletal elements. The perichondrium and
perioseum are generated around the nascent cartilage, and
cells surrounding the zone of hypertrophic chondrocytes
begin to differentiate into osteoblasts. Sox9 is expressed in
all chondroprogenitors and chondrocytes except hyper-
trophic chondrocytes, and is required for the sequential
steps of chondrogenesis before and after mesenchymal
condensations [13,14].
Thus, in osteoblastic differentiation, the functional mech-
anisms of transcriptional regulators have been well eluci-
dated, however the exact roles of extrinsic molecules in
osteoblastic differentiation are less clear. In our microar-
ray screening aiming to identify novel molecular path-
ways in chondrocyte differentiation, we identified a novel
gene encoding a transmembrane protein, which is pre-
dominantly expressed in osteoblasts during mouse devel-
opment. We named this gene obif  (osteoblast induction
factor) and performed functional analyses using cell cul-
ture models.
We found that obif overexpression in the preosteoblastic
MC3T3-E1 cells induces differentiation and maturation of
osteoblasts. Knockdown of obif suppresses osteoblastic 
differentiation of MC3T3-E1 cells. We also present data
demonstrating that the extracellular domains of both
mouse and human obif proteins augment osteoblastic dif-
ferentiation-induction activity, suggesting that obif acts in
a ligand-like manner. Together, our results suggest that
obif  is involved in the differentiation of osteoblasts
through intercellular interaction during development.
Results
Identification and intracellular localization of obif protein
With the aim of identifying novel molecules involved in
chondrocyte differentiation, we performed a microarray
screening using a mouse chondroprogenitor cell line,
ATDC5 (Figure 1A). We extracted total RNA at day 0 (the
confluence stage), day 9 (the cartilage nodule formation
stage), and day 37 (the cellular hypertrophy and calcifica-
tion stage). With the gene expression profile analysis, we
identified 131 probe sets that showed more than a three-
fold change in expression level at day 9 or day 37 relative
to day 0. From among these genes, we selected 25 genes
that have not as yet been known to be associated with
chondrogenesis and osteoblastogenesis, and further
investigated their expression patterns. We found one gene
that shows an expression pattern predominantly in the
skeletal systems of mouse embryos and up-regulation
upon differentiation in ATDC5 cells. On the basis of our
functional assay, we named this gene obif (osteoblast induc-
tion factor) (GenBank TPA #BC025600) (Figure 1B) which
is the same gene with transmembrane protein 119
(tmem119).
The deduced amino acid sequence of mouse obif contains
a signal sequence, a single transmembrane domain, and a
glutamic acid-rich region. This gene is conserved among
species from chicken to human (Figure 1C and Additional
file 1). We also isolated a human OBIF cDNA from com-
mercially available human fetal brain RNA by RT-PCR.
The genomes of zebra fish and Xenopus tropicalis also con-
tain sequences that are homologous to mouse obif (data
not shown). We then examined the subcellular localiza-
tion of obif. Using a retrovirus vector, we overexpressed a
FLAG-tagged obif in various cell lines. To confirm the obif
expression, we performed Western blot analysis using
anti-FLAG M2 antibody and the antibody that we raised
against obif (Figure 1D). With both of these antibodies,
we detected a strong band of approximately 37 kD, a weak
band of approximately 44 kD, and broad bands of 50 - 75
kD in all cell lines in which obif was overexpressed (Figure
1D). Using the on-line predictor method NetOGlyc 3.1
[15], we found several potential O-glycosylation sites
between the signal sequence and transmembrane domain
of obif (Additional file 1). This observation strongly sug-
gests that obif is a type Ia transmembrane protein in
which the N-terminal region is frequently modified post-
transcriptionally. Next, we examined the intracellularBMC Developmental Biology 2009, 9:70 http://www.biomedcentral.com/1471-213X/9/70
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localization of obif using MC3T3-E1 cells stably overex-
pressing mouse obif (MC3T3-obif) or human OBIF
(MC3T3-OBIF) by immunostaining (Figures 1E-H). Obif/
OBIF are mainly localized to the plasma membrane. This
observation is coincident with the result of Western blot
analysis on the subcellular fractionated samples (Figure
1I), in which the microsomal fraction contained an abun-
dant amount of obif compared with the cytoplasmic frac-
tion.
Obif transcript is expressed in osteoblast-lineage cells
Early mouse embryos were examined for obif transcript
expression by whole mount in situ hybridization (Figures
2A and 2B). No clear hybridization signal was detected at
E8.5 (data not shown). At E9.5, the signal was seen in the
whole limb buds (Figure 2A). At E12.5, the stage the car-
tilage primordiums were formed in the limb buds, obif
transcripts were observed in the areas between these pri-
mordiums (Figure 2B).
We then compared the expression of obif with that of the
chondrocytic marker Sox9 (Figures 2C-P). In the forelimb
bud, obif is expressed in a broad region at E9.5 (Figure
2A). At E10.5 and E11.5, the signal is down-regulated in
the proximal region where mesenchymal cells condense
and differentiate into chondrocytes, as evidenced by the
onset of Sox9 expression (Figures 2C, D, G, and 2H). At
E12.5 and E13.5, while Sox9 shows a prominent signal in
future digit regions, the expression of obif is most abun-
dant in the interdigital mesenchyme (Figures 2E, F, I, and
2J). As in developing limb buds, obif expression is comple-
mentary to that of Sox9 in other tissues (Figures 2D, H, K-
P). For instance, obif is expressed in cells between the con-
densations that form the future ribs at E11.5 (Figure 2D)
and in the osteogenic mesenchyme surrounding Meckel's
cartilage at E12.5 (Figures 2K-M). However, we could not
detect  obif  transcripts in the chondrocyte-lineage cells
such as the cartilage condensation and Meckel's cartilage
where Sox9 is expressed (Figures 2C-P).
To investigate the obif transcript expression at later embry-
onic stages, we performed section in situ hybridization
with several markers pertaining to endochondral ossifica-
tion (Figures 2Q-Y). Collagen1(Col.1) and osteocalcin (ocn)
are markers for mature osteoblasts. Osteopontin (opn) is a
marker for both terminally differentiated chondrocytes
and osteoblasts, and collagen 10 (col.10) is a marker for
hypertrophic chondrocytes. Interestingly, the expression
of obif was observed in the osteoblasts. In E14.5 humerus,
obif transcripts were detected in the perichondrium of the
hypertrophic chondrocyte region where collagen1  is
expressed, but were absent from more centrally located
chondrocytic cells (Figures 2Q and 2R). At E15.5, when
ocn is not yet significantly expressed, obif is detected both
in the prospective bone collar region marked with
collagen1 and in the developing bone trabeculae marked
with opn (Figures 2S-V). At E17.5, obif expression overlaps
with ocn but not with collagen10 (Figures 2W-Y).
Next, we examined the expression of obif and Runx2 in
various tissues of 4 week-old mice by Northern blot anal-
ysis (Figure 2Z). A 2.1 kb band was detected in the tissues
containing osteoblasts (calvaria, long bones) and other
tissues such as the brain and lung. The calvaria band was
significantly stronger as compared with that of the brain
or lung. High levels of obif expression at embryonic stages
followed by decreased expression of obif at early postnatal
stages suggest that obif works in both embryonic skeletal
development and postnatal differentiation. During post-
natal development, expression in calvaria and long bones
decreases whereas Runx2 expression is comparably main-
tained (Figure 2AA), suggesting that obif does not have an
important role in mature adult tissues.
Obif expression is up-regulated during osteoblastic 
differentiation in cell line models
Several cell lines derived from mesenchymal tissues have
been widely used to recapitulate in vivo cellular differenti-
ation [16-20]. We used preosteoblastic MC3T3-E1 cells,
Identification of a novel plasma membrane protein, obif, and its subcellular localization Figure 1 (see previous page)
Identification of a novel plasma membrane protein, obif, and its subcellular localization. (A) The strategy of 
microarray-based screening to identify up-regulated genes in chondrocyte differentiations of ATDC5 cell line. (B) Fold changes 
of representative chondrocyte markers (black) and obif (red) transcripts which are up-regulated in the microarray analysis. (C) 
Schematic diagram of obif protein structure. The percent sequence identities of each region are shown: SP, signal peptide; TM, 
transmembrane domain; E-rich, glutamic acid-rich domain. Numbers represent amino acid residues. (D) Detection of FLAG-
tagged obif protein. Whole cell lysates of MC3T3-obif, MC3T3-cont, ATDC5-obif, ATDC5-cont, and NIH3T3-obif were elec-
trophoresed by SDS-PAGE. Immunoblots were probed with anti-FLAG M2 antibody or anti-obif antibody. Arrows represent 
the molecular size of obif protein predicted from its amino acid sequences (29.4 kDa). (E-H) Confocal analysis of overex-
pressed mouse and human obif in MC3T3-E1 cells. Cells expressing FLAG-tagged mouse obif were stained with anti-obif anti-
body (red) (E, F). Cells expressing FLAG-tagged human OBIF were stained with anti-FLAG M2 antibody (red) (G, H). Nuclei 
were stained with DAPI (blue). Scale bar = 50 μm. (I) Subcellular localization of obif protein. Subcellular fractions of ST2 cells 
expressing exogenous mouse obif were analyzed by Western blotting. Immunoblots were probed with an anti-obif antibody to 
localize obif (top) and with an antibody against β-actin, an abundant cytoplasmic protein (bottom).BMC Developmental Biology 2009, 9:70 http://www.biomedcentral.com/1471-213X/9/70
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Figure 2 (see legend on next page)
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myogenic C2C12 cells, and stromal ST2 cells as osteoblast
differentiation models, and chondrogenic ATDC5 cells as
a chondrocyte differentiation model. Initially, the endog-
enous obif in these cells was examined in comparison with
Runx2 by Northern blot analysis (Figure 2BB). In undiffer-
entiated MC3T3-E1 cells only a faint signal was detected,
however, upon induction by ascorbic acid (AA) and β-
glycerophosphate (BGP), obif  transcripts dramatically
increased (Figure 2BB: lanes 1 and 2). Similarly, although
ATDC5 cells express almost no obif transcript in an undif-
ferentiated state, obif expression is markedly up-regulated
during differentiation induced by ITS (insulin/transferrin/
sodium selenite) (Figure 2BB: lanes 3 and 4). NIH3T3
cells express a low amount of obif and Runx2 transcripts
(Figure 2BB: lane 5). In C2C12 cells, obif  expression
increased during osteoblastic differentiation induced by
BMP2 (Figure 2BB: lanes 6-8). In ST2 cells, obif expression
increased during differentiation induced by ascorbic acid
or Wnt 3a (Figure 2BB: lanes 9 and 10, and Figure 2CC:
lanes 1-4).
Endogenous obif protein is expressed in osteoblast-lineage 
cells
In order to investigate the localization of endogenous obif
protein, we immunostained sections of embryonic fore-
limb and humerus using the anti-obif antibody (Figures
3A-E). Signals were observed in the perichondrium of the
hypertrophic chondrocyte region, peripheral layers of the
endochondral skeletal elements, and cells associated bone
trabeculae including both the spindle-shaped osteoblasts
and the cuboidal-shaped osteoblasts. In addition, we
observed that obif appears to be expressed in the plasma
membrane of osteoblasts (Figures 3C and 3E). To verify
the expression of obif protein in osteoblast-lineage cells,
we performed double staining of the developing limb
using the obif antibody with other osteoblastic markers
such as alkaline-phosphatase (ALP) and collagen 1 (Fig-
ures 3F-I). At late embryonic stages, co-localization of obif
with ALP or with collagen type I was observed in the
femur (Figures 3F and 3G) and hindlimb (Figures 3H and
3I).
Next, we examined obif protein expression in primary cul-
tures of fetal mouse calvaria (Figures 3J-O). When calvar-
ial cells were sparsely cultured, no obvious obif signals
were observed (Figures 3J and 3M). On the other hand,
when densely cultured cells were stimulated with osteob-
lastic differentiation medium, strong obif expression was
detected (Figures 3K and 3N). By western blot analysis
using primary culture cells and MC3T3-E1 cells, the eleva-
tion of the protein level was observed during calvarial cell
maturation (Figure 3P).
The role of obif in osteoblastogenesis
We then performed cell differentiation analysis using the
retrovirus vector. For the overexpression study, cells were
infected with retroviruses expressing both obif and GFP
through IRES or expressing GFP only as a control. The
infection efficiency was monitored by GFP expression
(Additional file 2A, D, G, and 2J). Obif expression was
confirmed by immunocytochemistry (Additional file 2C
and 2I) and Western blot analysis using anti-obif anti-
body (Figure 1D). These results show that cultured cells
can be infected efficiently (>95%) with retroviruses. These
infected cells express GFP and/or obif protein even after
extensive passaging. For gene knockdown, we made retro-
viruses expressing short hairpin RNAs (shRNAs) against
obif. First, we designed three different siRNAs (siRNA-1,
Predominant expression of obif transcript in osteoblast-lineage cells Figure 2 (see previous page)
Predominant expression of obif transcript in osteoblast-lineage cells. (A, B) Expressions of obif in mouse embryos 
examined by whole mount in situ hybridization. (C-P) In situ hybridization analysis of mouse obif and Sox9 in the developing 
mouse limb, rib, and mandible. Obif expression was complementary to that of Sox9 in the developing limb bud (C-J), rib (D, H) 
and mandible (K-P). FL, forelimb; HL, hindlimb; NT, neural tube; to, tongue; m.c., Meckel's cartilage. Scale bars = 200 μm. (Q-
Y) Section in situ hybridization of mouse obif in endochondral ossification. At E14.5 obif transcripts were detected in the peri-
chondrium but were absent from more centrally located chondrocytic cells (Q, R). In E15.5 humerus and E17.5 tibia, obif 
expression was found in cells associated with bone trabeculae and in cells associated with the formation of bone collars (S-Y). 
Scale bars = 200 μm. (Z) Northern blot analysis of obif and Runx2 expression in 4 week-old mouse tissues. The arrow corre-
sponds to a 2.1 kb obif transcript. (AA) Northern blot analysis of obif and Runx2 expression in the calvaria and humeri har-
vested from newborn, 3 week-old, and adult mice. (BB, CC) Northern blot analysis of obif and Runx2 transcripts in cell 
differentiation models of osteoblasts and chondrocytes. Total RNAs, extracted from MC3T3-E1 cells (BB: lane 1, undifferenti-
ated cells; lane 2, cells cultured in differentiation medium for 24 days), ATDC5 cells (BB: lane 3, undifferentiated cells; lane 4, 
cells cultured in differentiation medium for 21 days), NIH3T3 cells (BB, lane 5), C2C12 cells (BB: lane 6, undifferentiated cells; 
lane 7, cells cultured in myogenic differentiation medium for 6 days; lane 8, cells cultured in osteoblastic differentiation medium 
for 6 days), and ST2 cells (BB: lane 9, cells cultured in growth medium; lane 10, cells cultured in medium supplemented with 
Wnt3a and ascorbic acid for 4 days; and CC: lane 1, cells cultured in growth medium for 4 days; lane 2, cells cultured in 
medium with Wnt3a and ascorbic acid for 4 days; lane 3, cells cultured in medium with Wnt3a and ascorbic acid for 14 days; 
lane 4, cells cultured in medium with ascorbic acid for 14 days) were used for Northern blot analysis.BMC Developmental Biology 2009, 9:70 http://www.biomedcentral.com/1471-213X/9/70
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Figure 3 (see legend on next page)
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siRNA-2, and siRNA-3) and examined their knockdown
effects (Additional file 3). MC3T3-obif cells and ATDC5-
obif cells were transfected with siRNA-1, siRNA-2, siRNA-
3, or control siRNA and analyzed by Western blotting.
Non-transfected MC3T3-obif cells and ATDC5-obif cells
were also electrophoresed. All of the siRNAs against obif
showed strong knockdown effects (Additional file 3).
Next, we made retroviral constructs overlapping the effec-
tive siRNA sequences, a control shRNA (sh-cont), sh292
which sequence overlaps siRNA-1 and siRNA-2
sequences, and sh301 which sequence overlaps siRNA-3
sequence. When infected, MC3T3-obif cells with sh292
retroviruses showed a strong knockdown effect and those
with sh301 retroviruses showed a comparatively weak
knockdown effect (Additional file 3). Using these retrovi-
ruses, we established cells stably expressing these shRNAs
and performed knockdown studies.
Initially, we examined the effect of obif overexpression on
cell growth (Figures 4A and 4B). The proliferation rate
decreased somewhat in MC3T3-obif cells compared with
MC3T3-control (MC3T3-cont) cells (Figure 4A). The same
effects of exogenous obif were observed in other cell lines,
ATDC5, ST2, and C2C12 (data not shown). On the other
hand, MC3T3-sh292 and -sh301 cells showed almost the
same cell growth as cells infected with control retrovirus
(MC3T3-sh-cont) (Figure 4B). This result indicates that
effect of obif on cell differentiation described below is not
mainly due to the effects on cell growth.
Next, we investigated the relationship between obif expres-
sion and osteoblast differentiation. We first examined an
early stage osteoblastic marker, ALP activity. The retrovi-
rally infected cells were cultured in osteoblast differentia-
tion media and harvested at the indicated time points
(Figures 4C and 4D). While ALP activity increased in a
time-dependent manner both in MC3T3-obif and -cont
cells, MC3T3-obif cells showed a significantly higher ALP
activity than the MC3T3-cont cells at all points examined
(Figure 4C). In contrast, the reduction of obif expression
caused a significant decrease of ALP activity at all time
points examined (Figure 4D). Second, we cultured
MC3T3-E1 cells in the differentiation-induction medium
until mineralized nodules could be observed. Mineraliza-
tion was visualized by Alizarin Red staining and quanti-
fied by a biochemical assay for calcium. A significantly
higher degree of mineralization was obtained in MC3T3-
obif cells than in MC3T3-cont cells (Figures 4E-H). A
quantitative analysis of calcium by extraction of the calci-
fied mineral also showed a higher calcium content in
MC3T3-obif cells (Figure 4M). In contrast, decreased min-
eralization was observed in MC3T3-sh292 cells and
MC3T3-sh301 cells as compared with MC3T3-sh-cont
cells (Figures 4I-L and 4N). In addition, we examined the
effect of human OBIF on mineralization and confirmed
that it also promoted mineralization (Additional file 4).
Aiming to investigate the effect of obif at the molecular
level, we examined the expression of osteoblast lineage-
associated genes by Northern blot analysis (Figures 5A-
D). In obif overexpression experiments, the mRNA levels
of the osteoblastic differentiation markers increased in
MC3T3-obif cells compared with those in MC3T3-cont
cells. In particular, the elevations of bsp and ocn mRNA
levels were prominent (Figure 5A). In knockdown experi-
ments, obif transcripts were almost completely abolished
in MC3T3-sh292 cells and partially ablated in MC3T3-
sh301 cells (Figures 5B-D). As early and essential osteob-
lastic markers, we first examined Runx2 and Osx mRNA
levels (Figure 5B). At day 14, Osx transcripts decreased in
obif knocked down cells whereas Runx2 transcripts were
not influenced by obif levels. At day 28, Runx2 was down-
regulated in MC3T3-sh292 cells while we could detect
only faint evidence of obif mRNA. To investigate the rela-
tionship between Runx2 and obif, we established Runx2
knocked down MC3T3-E1 cells (MC3T3-shRunx2) and
compared with obif knocked down cells (Figure 5C). In
MC3T3-shRunx2 cells, obif was down-regulated whereas
Predominant expression of obif protein in osteoblast-lineage cells Figure 3 (see previous page)
Predominant expression of obif protein in osteoblast-lineage cells. (A-E) Immunostaining of developing limbs using 
anti-obif antibody. Sections of limbs were stained with anti-obif antibody (red) and nuclei were stained with DAPI (blue). E15.5 
forelimb sections (A, B). Scale bars = 200 μm. E17.5 humerus sections (C). Obif was expressed in spindle-shaped osteoblasts 
lining trabecular bone surfaces and in cuboidal-shaped osteoblasts. Scale bars = 50 μm. Higher magnification of E17.5 humerus 
sections shows that obif is localized to the plasma membrane (D, E). White arrows indicate typical cells that show the trans-
membrane pattern. (F, G) E 18.5 femur section was first stained with anti-obif antibody (green) and then stained for ALP. (H, I) 
E 18.5 hindlimb section was double-stained with anti-obif antibody (red) and anti-collagen I antibody (green). (J-O) Primary cal-
varial cells cultured in 12-well plates were immunostained with anti-obif antibody (J-L) and DAPI (M-O). Sparsely cultured cells 
(J, M). Densely cultured cells were incubated in presence of ascorbic acid for 23 days and used for analysis (K-O). L & O are 
negative controls. (P) Detection of endogenous obif protein. Whole cell lysates of calvarial cells-obif (stably infected), calvarial 
cells-day 0 (not stimulated), calvarial cells-day 23 (stimulated for 23 days), MC3T3-E1 cells-day 0 (not stimulated), MC3T3-E1 
cells-day 8 (stimulated for 8 days), and MC3T3-E1 cells-day 14 (stimulated for 14 days) were electrophoresed by SDS-PAGE. 
Immunoblots were probed with the anti-obif antibody. Calvarial cells-obif is a positive control.BMC Developmental Biology 2009, 9:70 http://www.biomedcentral.com/1471-213X/9/70
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Runx2 was not affected in MC3T3-sh292 cells at day 8.
These results concur with a previous report that suggests
obif is a downstream gene of Runx2 [21]. Furthermore, obif
promoters contain a number of putative Runx2 binding
sites in multiple species (Additional file 5). Next, we
examined ocn mRNA levels in obif knocked down cells
(Figure 5D). At day 14 and 28, ocn was down-regulated in
both MC3T3-sh292 and -sh301 cell. At day 42, the ocn
mRNA level in MC3T3-sh301 cells is almost the same as
that in the control cells whereas it is significantly lower in
MC3T3-sh292 cells. In primary culture cells, ocn mRNA
was down-regulated in obif knocked-down cells (Figure
5E).
Extracellular domain of obif can promote osteoblastic 
differentiation
Obif protein is a single pass transmembrane protein that
localizes to the plasma membranes. In order to investigate
the mechanism of obif function, we made two more retro-
viral constructs. One expresses the N-terminal extracellu-
lar domain (ECD), and the other expresses both the ECD
and the transmembrane domain (TM) (Figure 6A). Using
retroviruses derived from these constructs, we established
cells stably expressing partial obif proteins. Both bands of
the partial proteins detected by Western blot were larger
than their predicted sizes (Figure 6B). Immunocytochem-
istry analyses using an anti-FLAG antibody showed differ-
ent subcellular localizations of these genes (Figures 1F,
6C, and 6D). Proteins including the TM localized to the
plasma membranes whereas a large amount of obif-ECD
protein localized to the cytoplasm.
Then, we examined the effects of partial obif proteins on
the induction of ALP activity and matrix mineralization.
MC3T3-ECD and -ECD+TM cells showed strong ALP
activities similar to MC3T3-obif cells at all points exam-
ined (Figure 6E). Partial obif proteins also stimulated
mineralization at days 28 and 42 (Figure 6F). Similar
results were observed in experiments using retroviruses
expressing partial proteins of human OBIF (Additional
file 6).
Next, we generated an obif-fusion protein, consisting of
the obif extracellular domain fused to an AP tag. Bands of
predicted sizes were detected in lysates from transfected
cells by Western blotting using an anti-AP antibody (Fig-
ure 6G). On the other hand, in supernatants from trans-
fected cells, bands of larger sizes were detected. When
tested for binding to tissue sections and cultured cells, AP-
obif (ECD) bound to bone tissues and differentiating
MC3T3-E1 cells (Figures 6I, K, and data not shown). In
contrast, the control AP protein did not bind at detectable
levels (Figures 6H and 6J).
Discussion
We have isolated and functionally characterized a novel
plasma membrane protein, obif. Obif is highly expressed
in early and late stage osteoblasts of developing mouse
embryos, and its transcripts increase during osteoblastic
differentiation in several skeletal cell lines. In preosteob-
lastic MC3T3-E1 cells, differentiation, particularly matrix
mineralization, is stimulated when obif is overexpressed,
and inhibited when obif is knocked down. Furthermore,
we showed that the extracellular domain of obif protein
can promote MC3T3-E1 differentiation like the full-
length form of obif, suggesting that obif functions in a lig-
and-like manner.
Although obif was originally isolated as a molecule that is
up-regulated during ATDC5 cell differentiation, we could
not detect clear obif/obif expression in chondrocyte-line-
age cells in mouse skeletal tissues. This seems due to obif
up-regulation by cells surrounding the cartilage nodules
during ATDC5 differentiation.
Osteoblastogenesis is a multistep process temporally con-
trolled by transcription factors and secreted growth fac-
tors. The centerpiece of the transcriptional control of
osteoblast differentiation is the Runx2-dependent path-
way. Runx2-deficient mice have a cartilaginous skeleton
without any osteoblasts, as osteoblast differentiation is
arrested as early as E12.5 [6]. Osterix, a zinc finger-con-
taining protein that is known to be downstream of Runx2,
The role of obif in the osteoblastic differentiation of MC3T3-E1 cells Figure 4 (see previous page)
The role of obif in the osteoblastic differentiation of MC3T3-E1 cells. (A, B) Effect of obif expression on cell growth in 
the MC3T3-E1 cells. The proliferation rate decreased somewhat in MC3T3-obif compared with MC3T3-cont (A). Cells 
infected with retroviruses expressing shRNA against obif (MC3T3-sh292, MC3T3-sh301) showed almost the same level of cell 
growth with MC3T3-sh-cont (B). (C) Effect of obif expression on ALP activity in MC3T3-E1 cells cultured in the presence of 
ascorbic acid and β-glycerophosphate. (D) Effect of expression of shRNAs against obif in MC3T3-E1 cells. The reduction of obif 
expression caused a significant decrease of ALP activity at all time points. The decrease was proportionate to the strength of 
the shRNA's knockdown effects. (E-N) Mineral deposition visualized by Alizarin Red staining (E-L), and calcium contents meas-
ured by a colorimetric assay (M, N). The mineral deposition observed in MC3T3-obif cells and MC3T3-cont cells at days 18 
and 24 (E-H). The mineral deposition observed in MC3T3-sh301 cells compared to MC3T3-sh-cont cells at days 30 and 46 (I-
L). Scale bars = 2 mm. Calcium contents were significantly higher in MC3T3-obif cells than in MC3T3-cont cells both at day 18 
and day 26 (M). Calcium deposition in MC3T3-sh292/301 and MC3T3-sh-cont cells at days 30 and 46 (N).BMC Developmental Biology 2009, 9:70 http://www.biomedcentral.com/1471-213X/9/70
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is expressed in osteoblast progenitors, and mice without
Osterix also lack mature osteoblasts [7]. Although other
transcription factors, Dlx5/6, Msx1/2, AP-1 families, twist,
and ATF4, have been reported to be involved in osteoblas-
tic differentiation, exact roles of these factors and their
relationship with Runx2 remain to be elucidated [22-27].
A recent report suggests that obif (tmem119) is one of the
molecules downstream of Runx2 [21]. Our results are con-
sistent with this report. However, obif  expression is
observed as early as Runx2 expression in developing limb
buds and during the differentiation of MC3T3-E1 cells.
Therefore, the genetic and cell biological relationships
between obif and Runx2 will need future studies, including
analysis of obif and Runx2 mutant mice.
The effect of obif expression on osteoblastic markers Figure 5
The effect of obif expression on osteoblastic markers. (A-D) Northern blot analyses of osteoblastic differentiation 
markers in MC3T3-E1 cells. Comparison between MC3T3-obif cells and MC3T3-control cells (A). The overexpression of obif 
was confirmed in MC3T3-obif cells. Since the coding sequence of obif is connected with an IRES sequence in the retrovirus 
construct, transcripts produced are longer than endogenous obif transcripts. The mRNA levels of osteoblastic differentiation 
markers, in particular bsp and ocn increased in MC3T3-obif cells. The comparison among control cells (MC3T3-sh147) and obif 
knocked down cells (MC3T3-sh292, -sh301) (B-D). At day 14, Osx transcripts decreased in obif knocked down cells whereas 
Runx2 transcripts were not influenced by obif level (B). At day 28, Runx2 was down-regulated in MC3T3-sh292 cells where we 
could detect only faint levels of obif mRNA. In MC3T3-shRunx2 cells, obif was down-regulated whereas Runx2 was not affected 
in MC3T3-sh292 cells at day 8 (C). At day 14 and 28, ocn were down-regulated in both MC3T3-sh292 and -sh301 cells (D). At 
day 42, ocn mRNA level in MC3T3-sh301 cells is almost the same as that in the control cells, but significantly lower in MC3T3-
sh292 cells. (E) Semi-quantitative RT-PCR of osteoblastic differentiation markers in primary calvarial cells. The data presented 
are derived from three independent experiments.
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Figure 6 (see legend on next page)BMC Developmental Biology 2009, 9:70 http://www.biomedcentral.com/1471-213X/9/70
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In mouse embryos, cells expressing obif are observed in
the periosteum, bone collars, and trabecular bones. The
expression pattern of obif suggests that obif functions in
osteoblastic development. In the multiple cell line models
we used, endogenous obif is markedly upregulated during
osteoblastic differentiation. These expression patterns
strongly suggest that obif functions in osteoblastogenesis.
In committed preosteoblastic MC3T3-E1 cells, obif exerts
critical roles both in ALP induction and in matrix miner-
alization. In obif overexpression and knockdown experi-
ments, cell proliferation is mildly affected but the effect of
obif expression levels on differentiation is more signifi-
cant. Thus we propose that obif may play a role in both
proliferation and differentiation, but the primary effect of
obif is on differentiation. When obif is knocked down in
MC3T3-E1 cells, mRNA levels of Osx and ocn decrease pro-
portionally to the obif transcripts, although Runx2 is not
significantly affected. And in a similar experiment using
primary calvarial cells, the level of ocn transcript decreases
in cells in which obif was knocked down. These results
suggest that obif protein is involved in the late differenti-
ation of osteoblast-lineage cells.
Partial proteins including the ECD of both human and
mouse obif stimulated osteoblastic differentiation in
MC3T3-E1 cells as well as the full-length obif protein.
These results suggest that the ECD is sufficient to stimulate
osteoblastic differentiation, and the physiological func-
tion of obif is mediated by cell-cell or cell-matrix interac-
tion as a ligand. The binding activity of AP-obif (ECD) to
bone tissues and differentiating MC3T3-E1 cells supports
the hypothesis that an obif receptor-like molecule exists in
bone tissues and that obif functions as a ligand. Further
investigation of the functional mechanisms of obif may
shed light on a new signaling mechanism in osteoblast
and chondrocyte differentiation.
Conclusions
We have isolated and functionally characterized a novel
plasma membrane protein, obif. Obif is highly expressed
in early and late stage osteoblasts of developing mouse
embryos, and its transcripts increase during osteoblastic
differentiation in several skeletal cell lines. In preosteob-
lastic MC3T3-E1 cells, differentiation, particularly matrix
mineralization, is stimulated when obif is overexpressed,
and inhibited when obif is knocked down. Furthermore,
we showed that the extracellular domain of obif protein
can promote MC3T3-E1 differentiation like the full-
length form of obif, suggesting that obif functions in a lig-
and-like manner.
Methods
Reagents
Cell culture medium, α-modified minimum essential
medium (α-MEM), Dulbecco's modified Eagle's medium
(DMEM), a 1:1 mixture of DMEM and Ham's F-12
medium, ascorbic acid, β-glycerophosphate, and ITS Liq-
uid Media Supplement were purchased from Sigma. Fetal
bovine serum (FBS) was purchased from JRH Bioscience
(Nichirei, Japan). The following primary antibodies were
used: anti-FLAG M2 (Sigma), anti-β-actin clone AC-74
(Sigma), anti-collagen type I (Santa Cruz). Wnt3a-condi-
tioned medium was kindly provided by Dr. Shin Yone-
hara (Kyoto University). Recombinant human BMP2 was
provided by Osteopharma Inc. (Osaka). Obif  siRNA
(Stealth™ RNAs) duplexes were chemically synthesized by
Invitrogen. The obif  siRNA sequences were as follows:
siRNA-1, GCUCGCUGACCUUCCUCAUCAUGUU;
siRNA-2, UCGCUGACCUUCCUCAUCAUGUUCA;
siRNA-3, CCUUCCUCAUCAUGUUCAUAGUCUG.
Anti-obif antibody production
By using PCR, a cDNA encoding a C-terminal portion of
mouse obif (residues 113-280; obif-C) was amplified and
subcloned into pGEX4T-1 (Amersham Biosciences). The
fusion was expressed in Escherichia coli strain DH5α and
Extracellular domain of obif can promote osteoblast differentiation Figure 6 (see previous page)
Extracellular domain of obif can promote osteoblast differentiation. (A) Schematic representation of partial obif pro-
teins overexpressed in MC3T3-E1 cells. Upper: the full-length obif protein, middle: the partial obif fragment containing the N-
terminal extracellular domain (ECD), lower: the partial obif fragment composed of the ECD and the transmembrane domain 
(TM). Numbers represent amino acid residues of mouse (human) obif proteins. (B-F) MC3T3-E1 cells infected with retrovi-
ruses were cultured in the differentiation medium and used for assays. Both of bands of partial obif poteins detected by West-
ern blot were larger than predicted sizes (B). Immunocytochemistry analyses using anti-FLAG antibody (C-D). MC3T3-
ECD+TM protein localizes to the plasma membranes whereas a large amount of obif-ECD protein localizes to the cytoplasm. 
Scale bars = 50 μm. MC3T3-E1 cells infected with retroviruses expressing a full-length obif or its partial proteins showed ele-
vated ALP activities at all time points examined (E). Infection with retroviruses expressing full-length and partial proteins signif-
icantly promoted mineral deposition both at day 28 and 42 (F). (G) AP fusion proteins (obif-ECD-AP, AP-obif-ECD) and AP 
protein were detected by Western blotting analysis using anti-AP antibody. Fusion proteins in supernatants are larger than 
those in lysates from transfected cells. (H-I) AP-obif (ECD) bound to bone tissues whereas control AP protein did not bind at 
detectable levels. (J, K) Higher magnifications of the squares in H &I, respectively. Scale bars = 100 μm.BMC Developmental Biology 2009, 9:70 http://www.biomedcentral.com/1471-213X/9/70
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purified with glutathione Sepharose 4B (Amersham Bio-
sciences) according to the manufacturer's instructions. An
antibody against obif was obtained by immunizing rab-
bits with the purified GST-obif-C (MBL, Japan). The rabbit
antisera against obif-C was pre-absorbed with GST-Sepha-
rose and affinity purified with an immunizing fusion pro-
tein-bound Sepharose column.
Cell culture
ATDC5, MC3T3-E1, ST2, and C2C12 cells were obtained
from the RIKEN Cell Bank (Ibaraki, Japan). The ATDC5
cells were cultured in a maintenance medium of a 1:1
mixture of DMEM and Ham's F-12 medium, and 5% FBS.
MC3T3-E1 cells and ST2 cells were cultured in α-MEM
supplemented with 10% FBS. C2C12 cells were cultured
in DMEM containing 10% FBS. Primary mouse calvarial
cells were dissected from 2-day old pups. Calvarial cells
were isolated by four sequential 15-minute digestions in
collagenase/dispase solution (Roche 269638) at 37°C.
Fractions 2-4 were collected, resuspended in media and
plated. Freshly harvested cells of less than 4 passages were
used for all experiments.
Microarray gene expression profiles
RNA was harvested and purified with Trizol according to
manufacturer's protocol (Invitrogen). Preparation of
cRNA and hybridization of probe arrays were performed
according to the protocols of the manufacturer using the
GeneChip Mouse Genome 430 2.0 Array (Affymetrix,
Santa Clara, CA).
Production of recombinant retrovirus and infection
The retroviral vector expressing mouse or human obif was
constructed in the pBMN-I-GFP vector that was kindly
provided by Dr. Gary Nolan (Stanford University). In
brief, the full- or partial-length coding regions of mouse or
human obif cDNA that were added to the FLAG tag at the
C-terminus were inserted into the multicloning site of
pBMN-I-GFP. PCR were performed using FANTOM clone
[28] cDNA (#BC025600) or cDNA produced from
Human Fetal Brain Total RNA (purchased from Clon-
tech). Reduction of obif expression was achieved through
the retroviral infection of cells with short hairpin RNAs
directed against the obif  mRNA, using pSU-
PER.retro.neo+GFP (pSUP) plasmids (Oligoengine). 19-
nt target sequences were selected in the mouse obif and
Runx2 cDNA coding sequences as follows: obif sh292, 5'-
CGCTGACCTTCCTCATCAT-3' (292-310); obif sh301, 5'-
TCCTCATCATGTTCATAGT-3' (301-319); Runx2, 5'-
CCACTTACCACAGAGCTAT-3' (857-875). Each one was
used to design a 60-nt oligo, which was subcloned
between the BglII and HindIII restriction sites of the pSUP
vector according to the manufacturer's instructions. As a
control, the same set of experiments was performed using
an irrelevant sequence (Dharmacon Research). To pro-
duce the retroviral particles, the plasmid DNA was trans-
fected along with a helper plasmid into a subline of the
293T cell line; supernatant was collected every day starting
at 24 hr posttransfection for 3 days. For infection, cells
plated at low density were incubated in virus-conditioned
medium for 1-2 days in the presence of 8 μg/ml poly-
brene. Virus-conditioned medium was used in a 1:1 dilu-
tion with normal growth medium. In the case of infection
with retroviruses expressing shRNA, infected cells were
selected based on their resistance to G418.
Western blot analysis
Cells were harvested in lysis buffer (50 mM Tris-HCL
[pH7.5], 0.15 M NaCl, containing 1% NP-40, 1 μM
sodium orthovanadate). After sonication, cell debris was
removed by centrifugation, and the supernatants were col-
lected. Equal amounts of total proteins were then pre-
pared for Western blot analysis according to a previously
described protocol [29]. The primary antibody dilutions
were 1:1000 (anti-FLAG M2), 1:500 (anti-obif), and
1:5000 (anti-β-actin).
Subcellular localization analysis
Stably infected cells were used for localization analysis
according to a previously described protocol [29]. The pri-
mary antibodies were used at dilutions of 1:500 (anti-
FLAG M2) and 1:250 (anti-obif). For nuclear staining, we
added 4,6, -diamidino-2-phenylindole dihydrochloride
(DAPI, Sigma) at a dilution of 1:1000 in the secondary
antibody solution.
Subcellular fractionation
Cells were harvested in ice-cold buffered sucrose (0.25 M.
sucrose-10 mM Tris-HCl buffer [pH 7.5]) and whole-cell
lysates prepared by sonication were centrifuged in a
swinging bucket rotor at 80 × g for 5 min at 4°C. Then the
supernatant was spun at 12,000 × g for 10 min. The result-
ant pellet was designated the mitochondrial fraction. The
postmitochondrial supernatant was then subjected to cen-
trifugation at 100,000 × g for 90 min in a Beckman
TLA120.2 rotor at 4°C. The high-spin pellet was desig-
nated the microsomal fraction, and the supernatant was
designated the cytoplasmic fraction.
In situ hybridization and Northern blot analysis
Mouse  obif  (#BC025600),  Sox9  (#4933413I11), and
collagen1  (#D930048E22) cDNAs obtained from the
RIKEN FANTOM2 collection were used to prepare anti-
sense probes. A 540 bp fragment of mouse collagen2 and a
520 bp fragment of mouse collagen10 were obtained by
RT-PCR and subcloned into the pGEM-T Easy vectors
(Promega). Mouse osteopontin and osteocalcin cDNAs were
kindly provided by Dr. Toshihisa Komori (Nagasaki Uni-
versity, Japan). Whole mount in situ hybridization and
section in situ hybridization were performed as describedBMC Developmental Biology 2009, 9:70 http://www.biomedcentral.com/1471-213X/9/70
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previously [30]. Northern blot hybridization was per-
formed as described previously [31]. The entire protein
coding regions of obif, bsp, a 1-kb fragment of Runx2 cDNA
(nucleotides 280-1281), a 0.5-kb fragment of Osterix
cDNA (nucleotides 115-611), and a 0.47-kb fragment of
ocn cDNA (nucleotides 1-470) were used as radiolabeled
probes.
Immunohistochemistry
We followed the immunostaining procedures described
previously [32]. The specimens were observed under a
laser confocal microscope (LSM510, Carl Zeiss) or a fluo-
rescent microscope (Axioskop 2 Plus, Carl Zeiss).
Proliferation assay
Cells were plated at a density of 3 × 103 cells/cm2 and cul-
tured in growth medium. At each time point, cells were
harvested and counted using a haemocytometer. Dupli-
cate measurements were performed on three independent
wells for each time point.
Osteoblastic differentiation
MC3T3-E1 cells, ST2 cells: Cells were plated in 6-well or
12-well plates in triplicate at a density of 2.5 × 104 cells/
cm2 and were cultured in growth medium. One day after
the cells reached confluence, they were cultured in differ-
entiation medium (α-MEM containing 50 ug/ml ascorbic
acid and 2 mM β-glycerophosphate) or Wnt3a- condi-
tioned medium that was used at a 1: 3 dilution with nor-
mal growth medium. Determination of ALP activity,
Alizarin Red S staining and Ca2+ accumulation was done
as described elsewhere [33,34]. C2C12 cells: For BMP2
induction, cells were cultured in medium supplemented
with 2.5% FBS and 300 ng/ml recombinant human
BMP2.
Chondrogenic differentiation
After ATDC5 cells were plated in 6-well or 12-well plates
in triplicate at a density of 2.5 × 104 cells/cm2, differentia-
tion induction and evaluation of matrix proteoglycan syn-
thesis were performed as described elsewhere [35].
Semi-quantitative RT-PCR
One μg samples of RNA were subjected to reverse tran-
scription with a random hexamer as a primer, and semi-
quantitative PCR was performed for each gene using the
following primers: for mouse runx2, 5'-AAATGCCTC-
CGCTGTTATGAA (sense primer) and 5'-GCTCCG-
GCCCACAAATCT (antisense primer); for mouse collagen
1, 5'-CCCAAGGAAAAGAAGCACGTC (sense primer) and
5'-AGGTCAGCTGGATAGCGACATC (antisense primer);
for mouse ocn, 5'-CCGGGAGCAGTGTGAGCTTA (sense
primer) and 5'-AGGCGGTCTTCAAGCCATACT (antisense
primer); and for mouse β-actin  5'-CGTGCGTGACAT-
CAAAGAGAA (sense) and 5'-TGGATGCCACAGGATTC-
CAT (antisense). PCR conditions were 28 cycles of 94°C
for 20 sec, 55°C for 30 sec, and 72°C for 30 sec. Post PCR,
each sample was subjected to electrophoresis on a 2% aga-
rose gel and visualized by ethidium bromide staining.
Statistical analysis
Data were examined for distribution, variance homogene-
ity (F-test) and analyzed using Student's unpaired t-test (2
tailed) for all analyses. P < 0.05 was considered statisti-
cally significant. Unless otherwise specified, all data are
presented as mean ± SEM or mean + SE.
Production of the AP tag-obif fusion protein
We followed the procedures described previously [36].
Briefly, AP fusion proteins were produced by inserting the
extracellular domain of obif into the APtag-5 vector that
was kindly provided by Dr. Mitsuharu Hattori (Nagoya
City University). After producing conditioned medium
from transiently transfected 293T cells, we spun out debris
and filtered (0.45-μm pore size) the supernatant.
In situ analysis of AP tag-obif binding to tissue sections
We washed the sections in HBS and in HBAH buffer. AP
fusion proteins were added and incubated at room tem-
perature for 90 min. After a 15 min incubation in pre-
heated HBS, in a 65° water bath, BCIP/NBT substrate was
added.
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obif is conserved among species. The deduced amino acid sequences of 
chicken, mouse, rat, and human obif proteins. GenBank accession num-
bers for the sequences are chicken, XP_415183.1; mouse, BK006092; 
rat, NP_001100625.1; human, AAQ88755.1. All of them contain the 
N-terminal signal peptide, a single transmembrane domain, and a 
glutamic acid-rich region (E-rich). Black boxes indicate potential O-glyc-
osylation sites conserved among species.
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Additional file 2
Verification of overexpression of obif protein by immunostaining. 
MC3T3-E1 and ATDC5 cells were infected with retroviruses expressing 
both obif and GFP (MC3T3-obif) (A-C), (ATDC5-obif) (G-I) or express-
ing GFP only (MC3T3-cont) (D-F), (ATDC5-cont) (J-L), Cells were 
stained with anti-obif antibody (red) and nuclei were stained with DAPI 
(blue) (C, F, I, L).
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Additional file 3
Verification of knock down of obif protein by Western blot analyses. 
(Left) Western blot analysis of cell extracts from MC3T3-obif and 
ATDC5-obif. To knock obif down, each of three siRNAs designed against 
obif and a negative-control siRNA were transfected into cell lines. Non-
transfected cells were also electrophoresed. Blots were probed with anti-
obif antibody. (Right) Western blot analysis of MC3T3-obif infected with 
retroviruses expressing control sh-cont, sh301, and sh292. Blots were 
probed with anti-obif antibody. Sh292 sequence overlaps siRNA-1 and 
siRNA-2 sequences, and sh301 sequence overlaps siRNA-3 sequence. 
Suppressive effect of sh292 is significantly stronger than that of sh301.
Click here for file
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213X-9-70-S3.PDF]
Additional file 4
Calcium contents observed in MC3T3-E1 cells expressing human obif 
and control cells at days 18 and 26. Calcium contents were significantly 
higher in MC3T3-hOBIF cells than in MC3T3-cont cells both at day 18 
and 26.
Click here for file
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Additional file 5
Comparative analysis of obif gene promoter. Schematic illustration of 
chick, mouse, rat, and human obif promoter. Putative Runx2 binding 
sites are indicated by open triangle.
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Additional file 6
Retroviruses expressing human OBIF exhibited a similar effect on 
mineralization of MC3T3-E1 cells as those infected with mouse obif 
retroviruses. Infection with retroviruses expressing full-length and partial 
human OBIF significantly promoted mineral deposition at day 33.
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